Sign inGet started

Johnson Wendy S.

Insider CIK 1652822 · XGN Director · RPHM Chief Development Officer · APHB See Remarks, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
XGN EXAGEN INC. A Award deriv2023-06-092023-06-139,000— $09,000SEC↗
XGN EXAGEN INC. A Award deriv2022-06-162022-06-219,000— $09,000SEC↗
XGN EXAGEN INC. P Buy2021-09-032021-09-071,000$14.02 $14.0K1,000SEC↗
RPHM Reneo Pharmaceuticals, Inc S Sale2021-07-142021-07-15111,736$8.50 $949.8K0SEC↗
RPHM Reneo Pharmaceuticals, Inc M Exercise deriv2021-07-082021-07-09111,736— $00SEC↗
RPHM Reneo Pharmaceuticals, Inc M Exercise2021-07-082021-07-09111,736$1.97 $220.1K111,736SEC↗
XGN EXAGEN INC. A Award deriv2021-06-172021-06-219,000— $09,000SEC↗
XGN EXAGEN INC. A Award deriv2020-10-012020-10-0115,000— $015,000SEC↗
APHB AmpliPhi Biosciences Corp A Award deriv2017-09-072017-09-1110,900— $010,900SEC↗
APHB AmpliPhi Biosciences Corp P Buy2015-10-052015-10-071,000$4.43 $4.4K1,000SEC↗
APHB AmpliPhi Biosciences Corp A Award deriv2015-09-212015-09-2316,200— $016,200SEC↗
APHB AmpliPhi Biosciences Corp A Award deriv2015-09-082015-09-1049,965— $049,965SEC↗